Gingicaine Gel Strawberry Gel
Product Images NDC 10129-036

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Gingicaine Gel Strawberry (NDC 10129-036). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gingi-pak A Division Of The Belport, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Keep Reach Out Of Reach Of Children (Children Page 001)

A text panel containing a safety warning for Gingicaine Gel. It advises to keep all Gingicaine Gel products out of reach of children and to call a doctor immediately if Gingicaine is ingested or swallowed by a child, recommending following directions accordingly.*

FDA Label Image

Contraindications

A text panel focusing on the contraindications for Gingicaine Gel Strawberry Flavor, specifying it should not be used in patients with hypersensitivity to ester-type local anesthetics and is not for use in teething or children under 2 years old.*

FDA Label Image

Gingicaine Strawberry Jar Label

Drug Facts panel for Gingicaine Gel Strawberry containing 20% Benzocaine oral anesthetic. The label includes uses, allergy alert, warnings, directions, dosage and administration instructions, and cautions for dental, oral, and periodontal use. The product is a 1 oz (30 gm) topical anesthetic gel, strawberry flavor, manufactured by Gingi-Pak in California, USA.*

FDA Label Image

Gingicaine In Syringe Box

Packaging label for Gingicaine Gel Strawberry, a 200 mg/1 dose topical anesthetic gel containing 20% benzocaine for oral use. The label features the product name, strawberry flavor with images of strawberries, and manufacturer Gingi-Pak a Division of the Belport. It includes dosing instructions and product details, specifying a 0.81 oz (24 mL) package with syringes and tips.*

FDA Label Image

Active Ingredients (Gingicaine Active Ingredients 001)

A drug facts panel listing the active ingredient as Benzocaine 20% w/v with the purpose stated as Oral Anesthetic. This panel corresponds to Gingicaine Gel Strawberry, an oral and periodontal dental gel with 200 mg strength.*

FDA Label Image

Allergy Alert (Gingicaine Allergy Alert 001)

This image shows a drug facts text panel containing an allergy alert. It warns against use if there is a history of allergy to any 'caine' local anesthetics or FD&C Red #40.*

FDA Label Image

Avoid Excessive Heat (Gingicaine Avoid Excessive Heat)

A drug facts text panel heading that cautions to avoid excessive heat above 40 °C (104 °F). This is typically part of storage instructions on a pharmaceutical product label.*

FDA Label Image

Consult A Doctor (Gingicaine Consult A Doctor Gingicaine)

A drug information text panel providing warnings and usage instructions for Gingicaine Gel Strawberry. It advises consulting a doctor if sore throat symptoms are severe or persistent beyond specific durations, warns against eye contact, keeping the product out of children's reach, and seeking immediate medical help if excessive amounts are swallowed. It also cautions not to exceed the recommended dosage.*

FDA Label Image

Dosage And Admin001 (Gingicaine Dosage And Admin 001)

A text panel titled 'Dosage & Administration' providing instructions to dry mucosa prior to application and remove excess saliva before using Gingicaine Gel Strawberry.*

FDA Label Image

Dosage And Admin002 (Gingicaine Dosage And Admin 002)

A drug information text panel providing instructions on applying the local anesthetic gel. It advises using cotton rolls or saliva ejectors to minimize dilution, sterile cotton or gauze for application, cautions on avoiding cross-contamination, dosage limits, frequency of use up to four times daily, age restrictions, and recommendations for consulting a dentist or doctor for children under two years old.*

FDA Label Image

Indications (Gingicaine Indications 001)

Text panel providing indications for Gingicaine Gel Strawberry Flavor. It describes the use of anesthesia for mucous membranes of the oropharynx and minimizing pain associated with ulcers, needle puncture, deep scaling, and matrix band application, as well as aiding in dental impressions and intraoral radiographs for patients with excessive gag reflex.*

FDA Label Image

Precaution (Gingicaine Precaution 001)

A text panel titled 'Precautions' providing warnings for dentists regarding the application of the product. It advises avoiding use on severely traumatized mucosal areas or certain areas of the posterior pharynx, caution for patients with known drug sensitivities, especially to ester-type anesthetics, and avoidance of contact with local anesthetics to prevent sensitization.*

FDA Label Image

Uses (Gingicaine Uses 001)

A text panel titled 'Uses' listing conditions for symptom relief including minor dental procedures, minor gum injury, canker sores, sore throat, and minor mouth or gum irritations from dentures or orthodontic appliances.*

FDA Label Image

Inactive Ingredients (Inactive Ingredient Page 001)

A text panel listing three inactive ingredients: Polyethylene Glycol 3350, Polyethylene Glycol 400, and Potassium Sodium Saccharate. The page is mostly white with black text aligned left, no other visible information.*

FDA Label Image

Purpose (Purpose Page 001)

A text panel describing Gingicaine Gel as a topical anesthetic used by dentists just prior to an injection, typically spread on a patient's gum. The text is brief and focused on the product's application in dental procedures.*

FDA Label Image

Syringe Label

Label for Gingicaine Gel Strawberry, a topical anesthetic gel labeled for dental, oral, and periodontal use. The label includes the brand name GingiCaine, the labeler Gingi-Pak, contact information, usage warnings such as 'Not for Injection' and 'Destroy after Use,' reference and lot numbers, and expiration date of 03/2026. The NDC number 10129-036-04 is present.*

FDA Label Image

Warnings

This text panel presents warnings for Gingicaine Gel Strawberry, including that it is for external use only and may cause methemoglobinemia, a serious condition. It advises discontinuing use and seeking immediate medical attention if symptoms like pale or blue skin, headache, rapid heart rate, shortness of breath, dizziness, fatigue, or lack of energy occur. It also states not to use the product in children under 2 years of age.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.